Key Findings

🫀 GLP-1s Slash Heart Attack and Stroke Risk Better Than Other Diabetes Drugs

A massive real-world study of 296,676 adults with type 2 diabetes found that sustained GLP-1 use had the lowest 2.5-year risk of major cardiovascular events, followed by SGLT2 inhibitors, sulfonylureas, and DPP4 inhibitors. The difference wasn't small—comparing the worst performer (DPP4 inhibitors) to the best (GLP-1s), there was a 1.9% absolute difference in cardiovascular risk over just 2.5 years.

😴 FDA Approves First-Ever Sleep Apnea Medication

Tirzepatide just became the first medication ever approved by the FDA specifically for treating obstructive sleep apnea, marking a historic shift from symptom management with CPAP machines to weight-centered, disease-modifying treatment. This approval transforms sleep apnea from a mechanical airway problem into a chronic metabolic disease that can be treated with medication.

🧠 GLP-1s Boost Brain Function in Diabetics

A meta-analysis of 18 randomized trials involving 11,114 participants found that GLP-1 receptor agonists significantly improved cognitive test scores—boosting Mini-Mental State Exam scores by 1.33 points and Montreal Cognitive Assessment scores by 1.70 points compared to placebo. The brain benefits were even stronger with long-term use (≥24 weeks).

🦴 The Bone Loss Side Effect Nobody Saw Coming

Mouse studies revealed that tirzepatide causes significant bone loss through an unexpected pathway: it alters gut bacteria, specifically reducing Lachnospiraceae, which normally produces bone-protective compounds like evodiamine. When researchers transplanted the beneficial bacteria back, they could prevent the bone loss entirely.

💨 Unexpected Lung Protection from GLP-1s

A retrospective study of 3.4 million adults with type 2 diabetes found that GLP-1 users had 14% lower risk of lung cancer, 6% lower risk of respiratory infections, and 8% lower risk of pulmonary fibrosis compared to those taking DPP4 inhibitors. The lung benefits were completely unexpected and suggest these drugs have far-reaching anti-inflammatory effects.

💊 The Social Stigma of Medical Weight Loss

A study of 1,041 Americans found that people view weight loss achieved through Ozempic as requiring less effort and being less praiseworthy than diet and exercise alone—even when the medication is combined with lifestyle changes. Participants also believed Ozempic users experienced less genuine personal change or value shifts compared to those who lost weight through traditional methods.